Maxime Dely: What If Whole Blood Became the Standard Again in Massive Transfusion?
Maxime Dely, Therapeutic Solutions Sales Consultant at Terumo Blood and Cell Technologies, shared a post on LinkedIn:
“What if whole blood became the standard again in massive transfusion?
In the management of massive hemorrhage, current protocols are well established: alternating red blood cell concentrates, plasma, and platelets – a structured sequence designed to approximate whole blood.
But an important question is increasingly being raised:
Why not use leukoreduced whole blood directly?
The advantages are clear:
- A product that is inherently complete and balanced
- Simplified logistics (single storage condition and unified shelf-life considerations)
- More efficient inventory management
From a scientific standpoint, several recent studies indicate that whole blood offers efficacy comparable to component therapy, particularly regarding early survival and correction of coagulopathy.
Beyond clinical outcomes, this also prompts broader reflection on our organizational models.
And you – have your institutions already begun exploring this shift?”
Find more posts featuring Maxime Dely on Hemostasis Today.
-
Jun 23, 2026, 22:49Giovanni Merlino: Why Does Stress Hyperglycemia Worsen Stroke Outcomes?
-
Jun 23, 2026, 22:41Tareq Abadl: Coombs Test – The Key to Detecting Immune-Mediated Hemolysis
-
Jun 23, 2026, 22:32How WFH Impacted the Bleeding Disorders Community in 2025
-
Jun 23, 2026, 18:27Advancing Gene Therapy Research for Glanzmann Thrombasthenia – Glanzmann’s Research Foundation
-
Jun 23, 2026, 18:17What Every ITP Patient Wants to Know – ITP Support Association
-
Jun 23, 2026, 18:13Ahsan Fareed: Exploring Heart Failure Readmissions in Iron Deficiency Anemia
-
Jun 23, 2026, 18:09Swarnava Roy: Key Findings on Stress Erythropoiesis and Mitochondrial Retention in RBCs
-
Jun 23, 2026, 17:40Hossam El Benawi: How do We Predict Recurrence Post LVT Resoultion?
-
Jun 23, 2026, 17:39Nicolas Gendron: Do We Really Need All These Hemostasis Tests in Patients on DOACs?